Matches in SemOpenAlex for { <https://semopenalex.org/work/W3113241482> ?p ?o ?g. }
- W3113241482 abstract "Chronic myeloid leukemia (CML) is a malignant clonal proliferative disease. Once it progresses into the phase of blast crisis (CML-BP), the curative effect is poor, and the fatality rate is extremely high. Therefore, it is urgent to explore the molecular mechanisms of blast crisis and identify new therapeutic targets.The expression levels of miR-181d, RBP2 and NF-κB p65 were assessed in 42 newly diagnosed CML-CP patients and 15 CML-BP patients. Quantitative real-time PCR, Western blots, and cell proliferation assay were used to characterize the changes induced by overexpression or inhibition of miR-181d, RBP2 or p65. Luciferase reporter assay and ChIP assay was conducted to establish functional association between miR-181d, RBP2 and p65. Inhibition of miR-181d expression and its consequences in tumor growth was demonstrated in vivo models.We found that miR-181d was overexpressed in CML-BP, which promoted leukemia cell proliferation. Histone demethylase RBP2 was identified as a direct target of miR-181d which downregulated RBP2 expression. Moreover, RBP2 inhibited transcriptional expression of NF-κB subunit, p65 by binding to its promoter and demethylating the tri/dimethylated H3K4 region in the p65 promoter locus. In turn, p65 directly bound to miR-181d promoter and upregulated its expression. Therefore, RBP2 inhibition resulting from miR-181d overexpression led to p65 upregulation which further forwarded miR-181d expression. This miR-181d/RBP2/p65 feedback regulation caused sustained NF-κB activation, which contributed to the development of CML-BP.Taken together, the miR-181d/RBP2/p65 feedback regulation promoted CML-BP and miR-181d may serve as a potential therapeutic target of CML-BP." @default.
- W3113241482 created "2020-12-21" @default.
- W3113241482 creator A5004641857 @default.
- W3113241482 creator A5014319544 @default.
- W3113241482 creator A5017123078 @default.
- W3113241482 creator A5023587499 @default.
- W3113241482 creator A5023660539 @default.
- W3113241482 creator A5033632697 @default.
- W3113241482 creator A5037332893 @default.
- W3113241482 creator A5038436626 @default.
- W3113241482 creator A5041836364 @default.
- W3113241482 creator A5062158170 @default.
- W3113241482 creator A5078033989 @default.
- W3113241482 date "2021-03-25" @default.
- W3113241482 modified "2023-10-01" @default.
- W3113241482 title "miR-181d/RBP2/NF-κB p65 Feedback Regulation Promotes Chronic Myeloid Leukemia Blast Crisis" @default.
- W3113241482 cites W1579549201 @default.
- W3113241482 cites W1593555249 @default.
- W3113241482 cites W1987967876 @default.
- W3113241482 cites W2023779399 @default.
- W3113241482 cites W2026970599 @default.
- W3113241482 cites W2030917930 @default.
- W3113241482 cites W2036224487 @default.
- W3113241482 cites W2054086725 @default.
- W3113241482 cites W2056115325 @default.
- W3113241482 cites W2059255388 @default.
- W3113241482 cites W2060941303 @default.
- W3113241482 cites W2063824422 @default.
- W3113241482 cites W2068044096 @default.
- W3113241482 cites W2078130872 @default.
- W3113241482 cites W2079625864 @default.
- W3113241482 cites W2079898330 @default.
- W3113241482 cites W2082854050 @default.
- W3113241482 cites W2094097897 @default.
- W3113241482 cites W2095362270 @default.
- W3113241482 cites W2111098183 @default.
- W3113241482 cites W2113915484 @default.
- W3113241482 cites W2116180289 @default.
- W3113241482 cites W2131864553 @default.
- W3113241482 cites W2144590600 @default.
- W3113241482 cites W2145518292 @default.
- W3113241482 cites W2150291652 @default.
- W3113241482 cites W2160851769 @default.
- W3113241482 cites W2277896202 @default.
- W3113241482 cites W2326047596 @default.
- W3113241482 cites W2416032025 @default.
- W3113241482 cites W2514921286 @default.
- W3113241482 cites W2604287195 @default.
- W3113241482 cites W2888850090 @default.
- W3113241482 cites W2908700430 @default.
- W3113241482 cites W2920655227 @default.
- W3113241482 cites W2965930739 @default.
- W3113241482 cites W2982978804 @default.
- W3113241482 cites W2985308469 @default.
- W3113241482 cites W2990223547 @default.
- W3113241482 cites W2993663878 @default.
- W3113241482 doi "https://doi.org/10.3389/fonc.2021.654411" @default.
- W3113241482 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8027495" @default.
- W3113241482 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33842368" @default.
- W3113241482 hasPublicationYear "2021" @default.
- W3113241482 type Work @default.
- W3113241482 sameAs 3113241482 @default.
- W3113241482 citedByCount "6" @default.
- W3113241482 countsByYear W31132414822021 @default.
- W3113241482 countsByYear W31132414822022 @default.
- W3113241482 countsByYear W31132414822023 @default.
- W3113241482 crossrefType "journal-article" @default.
- W3113241482 hasAuthorship W3113241482A5004641857 @default.
- W3113241482 hasAuthorship W3113241482A5014319544 @default.
- W3113241482 hasAuthorship W3113241482A5017123078 @default.
- W3113241482 hasAuthorship W3113241482A5023587499 @default.
- W3113241482 hasAuthorship W3113241482A5023660539 @default.
- W3113241482 hasAuthorship W3113241482A5033632697 @default.
- W3113241482 hasAuthorship W3113241482A5037332893 @default.
- W3113241482 hasAuthorship W3113241482A5038436626 @default.
- W3113241482 hasAuthorship W3113241482A5041836364 @default.
- W3113241482 hasAuthorship W3113241482A5062158170 @default.
- W3113241482 hasAuthorship W3113241482A5078033989 @default.
- W3113241482 hasBestOaLocation W31132414821 @default.
- W3113241482 hasConcept C104317684 @default.
- W3113241482 hasConcept C127561419 @default.
- W3113241482 hasConcept C2778729363 @default.
- W3113241482 hasConcept C502942594 @default.
- W3113241482 hasConcept C54355233 @default.
- W3113241482 hasConcept C86803240 @default.
- W3113241482 hasConceptScore W3113241482C104317684 @default.
- W3113241482 hasConceptScore W3113241482C127561419 @default.
- W3113241482 hasConceptScore W3113241482C2778729363 @default.
- W3113241482 hasConceptScore W3113241482C502942594 @default.
- W3113241482 hasConceptScore W3113241482C54355233 @default.
- W3113241482 hasConceptScore W3113241482C86803240 @default.
- W3113241482 hasLocation W31132414821 @default.
- W3113241482 hasLocation W31132414822 @default.
- W3113241482 hasLocation W31132414823 @default.
- W3113241482 hasOpenAccess W3113241482 @default.
- W3113241482 hasPrimaryLocation W31132414821 @default.
- W3113241482 hasRelatedWork W2003872068 @default.
- W3113241482 hasRelatedWork W2108410775 @default.
- W3113241482 hasRelatedWork W2118774187 @default.
- W3113241482 hasRelatedWork W2169317390 @default.